
My Chemist is owned by Chemist Warehouse Group, a private Australian pharmacy retail company founded by Jack Gance and Mario Verrocchi in 2000. My Chemist operates as the group's premium pharmacy brand, complementing the flagship Chemist Warehouse discount chain. Chemist Warehouse Group operates over 500 stores across Australia.
Parent Company
Founded
2015
Status
Private
Headquarters
| Brand | Parent Company | Ownership Type |
|---|---|---|
| My Chemist | Chemist Warehouse Group | Brand division |
My Chemist's history is tied to Chemist Warehouse Group, which was founded in 2000 by Jack Gance and Mario Verrocchi in Melbourne, Victoria. Chemist Warehouse was established as a discount pharmacy retailer, offering prescription medications and over-the-counter health and beauty products at significantly lower prices than traditional pharmacies. The discount model disrupted the Australian pharmacy market, which had historically operated with relatively uniform pricing.
Chemist Warehouse grew rapidly through the 2000s and 2010s, expanding its store network across Australia. The company's aggressive pricing, large store formats, and extensive product range made it the dominant pharmacy retailer in Australia by store count and revenue.
My Chemist was established in 2015 as a complementary brand targeting a different customer segment. While Chemist Warehouse focuses on discount pricing and large-format warehouse stores, My Chemist offers a more curated product selection, enhanced customer service, and a premium store environment. My Chemist stores are typically located in shopping centers and high-street retail locations, with refined aesthetics that contrast with the warehouse-style Chemist Warehouse stores.
The brand employs pharmacists and trained health consultants who provide personalized advice on medications, vitamins, skincare, and other health and wellness products. My Chemist developed a range of private label health and beauty products sold exclusively through its stores.
In 2025, Chemist Warehouse Group merged with Sigma Healthcare in a deal that created a combined entity with over 900 pharmacy outlets across Australia. The merger combined Chemist Warehouse Group's retail pharmacy network with Sigma Healthcare's pharmaceutical distribution and wholesale capabilities. The merged company listed on the ASX, marking a shift from Chemist Warehouse Group's previous fully private status.
Is Chemist Warehouse Group owned by another company?
Following the February 2025 merger, Chemist Warehouse Group operates as part of Sigma Healthcare Limited, a publicly traded company on the ASX under the ticker SIG. CWG shareholders hold 85.75% of the combined entity, with the three founders (Mario Verrocchi, Jack Gance, and Sam Gance) collectively holding approximately 49%. The merger was structured as a reverse takeover, with Chemist Warehouse Group effectively becoming the controlling entity.
Is Chemist Warehouse Group publicly traded?
Yes, following the merger with Sigma Healthcare completed on 13 February 2025, the combined entity trades on the ASX under the ticker symbol SIG (Sigma Healthcare Limited). Prior to the merger, Chemist Warehouse Group was a private company. The reverse merger provided public market access while allowing the founders to maintain significant ownership and control.
When was Chemist Warehouse founded?
The first Chemist Warehouse store opened in 2000 in Melbourne, founded by Jack Gance, Sam Gance, and Mario Verrocchi. However, the pharmacy origins trace to 1972 when brothers Jack and Sam Gance purchased their first pharmacy in Reservoir, Melbourne. Mario Verrocchi joined the business in 1980, and in 1997 they established the MyChemist brand before launching the Chemist Warehouse discount format in 2000.
Who founded Chemist Warehouse?
Chemist Warehouse was founded by Jack Gance, Sam Gance, and Mario Verrocchi. Jack Gance is a qualified pharmacist who opened his first pharmacy with his brother Sam in 1972. Mario Verrocchi joined as a trainee in 1980 and became a partner in 1982. The three founders established MyChemist in 1997 and the Chemist Warehouse brand in 2000. Jack Gance also created the brands Le Specs, Le Tan, and Colours of Australis.
What is Chemist Warehouse Group's annual revenue?
For FY2025 (ended 30 June 2025), the merged Sigma Healthcare and Chemist Warehouse Group reported statutory revenue of A$6.0 billion, up 82.2% year over year. On a pro forma basis (as if merged from 1 July 2024), revenue was A$9.6 billion with EBIT of A$903.4 million. The Chemist Warehouse retail network alone achieved total sales to customers of A$10.3 billion, up 14% year over year. Normalised NPAT was A$579.1 million, up 40.1%.
How many Chemist Warehouse stores are there?
As of 30 June 2025, there were 588 Chemist Warehouse franchise stores across Australia, plus 77+ international stores in New Zealand, Ireland, and the UAE. The broader franchise network includes an additional 293 stores under the Amcal and Discount Drug Stores brands, totaling 881 franchise stores across Australia. The company opened 35 new CW stores in FY2025 and plans to continue expansion at a consistent cadence.
What is the Sigma Healthcare merger?
In December 2023, Chemist Warehouse Group announced its intention to merge with Sigma Healthcare through a reverse takeover. The merger was completed on 13 February 2025, creating Australia's largest retail pharmacy franchisor and full line pharmaceutical wholesaler. CWG shareholders hold 85.75% of the combined entity, with a A$700 million cash component. The merger combined CWG's retail expertise with Sigma's wholesale and distribution infrastructure. The synergy target has been upgraded to A$100 million per annum by year four post merger.
What brands does Chemist Warehouse Group own?
The group operates multiple pharmacy retail brands including Chemist Warehouse (588 stores), MyChemist (premium pharmacy format), Amcal (community pharmacy), and Discount Drug Stores (discount pharmacy). The group also owns the Wagner generics medicines brand, as well as Le Specs (eyewear), Le Tan (tanning and skincare), and Colours of Australis (cosmetics), all created by founder Jack Gance.
My Chemist operates under Chemist Warehouse Group's corporate responsibility framework. As a pharmacy retailer, the brand's sustainability considerations center on pharmaceutical ethics, responsible retailing, and community health access.
The brand's premium pharmacy format emphasizes personalized healthcare advice, proper medication counseling, and adherence to pharmaceutical regulations. Pharmacists at My Chemist stores provide prescription services, medication reviews, and health consultations.
Chemist Warehouse Group's store operations include energy-efficient retail environments and waste reduction programs. The group's supply chain works with pharmaceutical manufacturers and health product suppliers who must comply with Australian regulatory standards.
No independently verified sustainability certifications specific to My Chemist have been documented. The company's sustainability and community health claims are reported through Chemist Warehouse Group's corporate communications.
My Chemist has received limited independent industry awards. The brand's recognition comes primarily through its association with Chemist Warehouse Group's market position.
My Chemist received Gold recognition in the Quality Service Awards Australia, acknowledging customer service standards in the pharmacy sector. The award recognizes pharmacies that demonstrate consistent service excellence based on customer feedback.
Chemist Warehouse Group's market leadership as Australia's largest pharmacy retailer provides brand recognition for My Chemist through association. The group's 2025 merger with Sigma Healthcare was covered in Australian business media including the Australian Financial Review and business publications.
My Chemist has faced challenges typical of Australian pharmacy retailers, though no major brand-specific controversies have been documented.
Regulatory Compliance: As an Australian pharmacy retailer, My Chemist must comply with Pharmacy Board of Australia regulations, state pharmacy laws, and federal pharmaceutical regulations. The Australian pharmacy sector is highly regulated, with restrictions on pharmacy ownership, location, and dispensing practices. Specific violations or enforcement actions against My Chemist have not been publicly documented.
ACCC Scrutiny: Chemist Warehouse Group has faced regulatory scrutiny from the Australian Competition and Consumer Commission (ACCC) regarding market concentration and competitive practices. The ACCC has expressed concerns about Chemist Warehouse's market influence and control over banner stores. The 2025 merger with Sigma Healthcare received ACCC review, given the combined entity's significant market share in both pharmacy retail and pharmaceutical distribution.
Pharmacy Location Rules: My Chemist faces constraints from Australian Pharmacy Location Rules that govern where pharmacies can be established. These rules limit store expansion and market entry, requiring careful strategic planning for new locations.
Pricing and Positioning Challenge: My Chemist faces the ongoing challenge of maintaining premium positioning while offering competitive pricing in a market dominated by discount pharmacy models, particularly its sister brand Chemist Warehouse. The brand must differentiate itself sufficiently from the discount format to justify any price differences.
Sigma Healthcare Merger Scrutiny: The 2025 merger between Chemist Warehouse Group and Sigma Healthcare attracted regulatory and industry attention due to the combined entity's significant market share. Industry observers raised questions about the impact on independent pharmacies and pharmaceutical distribution competition.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Chempro | Australia | 1996 | Mass market | Australia | All Genders |
Market Positioning: My Chemist competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Chemist Warehouse Group, giving you alternative choices that support different corporate structures.
Healthcare PharmaceuticalsOwned by Chempro Chemists
Australian online pharmacy operated by Chempro Chemists from Molendinar, Queensland. Offers prescription medications, health products, and wellness items through digital platforms and mail-order delivery.
Pharmacy Direct is owned by Chempro Chemists, a private company, a different structure than My Chemist's parent.
Healthcare PharmaceuticalsOwned by Bausch + Lomb Corporation
Global eye health company and contact lens manufacturer founded in 1853, known for ULTRA, Biotrue One Day, and INFUSE lens lines. Public on NYSE and TSX under BLCO.
Bausch + Lomb operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GoodRx Holdings, Inc.
American healthcare technology platform providing prescription drug price comparison, discount coupons, and telehealth services to help consumers find affordable healthcare options.
GoodRx operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Herbalife Ltd.
Global nutrition and weight-management brand owned by Herbalife Ltd. and sold through independent distributors in more than 90 markets.
Herbalife operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by Alcon Inc.
Independent publicly traded global eye care company headquartered in Geneva, Switzerland, specializing in surgical equipment, contact lenses, and ophthalmic products. Spun off from Novartis in April 2019.
Alcon operates independently without a large parent corporation.
Healthcare PharmaceuticalsOwned by GE HealthCare Technologies Inc.
Independent publicly traded healthcare technology company spun off from General Electric in January 2023, providing medical imaging, diagnostics, and healthcare IT solutions globally.
GE HealthCare operates independently without a large parent corporation.
Discover popular brands and companies in the Healthcare & Pharmaceuticals category and related searches from other users.

Abbokinase (urokinase) is a thrombolytic medication historically used for pulmonary embolism and catheter clearance. Originally marketed by Abbott Laboratories, now owned by Microbix Biosystems as Kinlytic. FDA-approved since 1978.

Prescription isotretinoin brand developed by Roche and approved by the FDA in 1982 for severe nodular acne. Roche discontinued the brand name in the United States in 2009; the drug continues as Roaccutane in international markets.

Activase (alteplase) is a prescription thrombolytic medication manufactured by Genentech, a wholly-owned subsidiary of Roche. Used to treat acute ischemic stroke, heart attack, and pulmonary embolism.